VerifyMe, Inc.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
VRME$8.98+10.3%Stored close · as of Sep 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements Consolidated Balance Sheets (Unaudited)
PART I - FINANCIAL STATEMENTS
ITEM 1.
Consolidated Balance Sheets
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| (Unaudited) | ||
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash and cash equivalents | $3,519 | $4,353 |
| Accounts receivable, net of allowance for credit loss reserve, $21 and $10 as of March 31, 2026 and December 31, 2025, respectively | 818 | 857 |
| Note receivable, net of allowance for credit loss reserve, $12 and $12 as of March 31, 2026 and December 31, 2025, respectively | 1,988 | 1,988 |
| Unbilled revenue | 285 | 338 |
| Prepaid expenses and other current assets | 208 | 154 |
| Inventory | 31 | 37 |
| TOTAL CURRENT ASSETS | 6,849 | 7,727 |
| PROPERTY AND EQUIPMENT, NET | $16 | $20 |
| INTANGIBLE ASSETS, NET | 2,325 | 2,345 |
| GOODWILL | 2,926 | 2,926 |
| TOTAL ASSETS | $12,116 | $13,018 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $532 | $745 |
| Other accrued expense | 457 | 530 |
| Convertible note – related party, current | 400 | 400 |
| Convertible note, current | 350 | 350 |
| TOTAL CURRENT LIABILITIES | 1,739 | 2,025 |
| TOTAL LIABILITIES | $1,739 | $2,025 |
| STOCKHOLDERS' EQUITY | ||
| Series A Convertible Preferred Stock, $0.001 par value, 37,564,767 shares authorized; 0 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | - | - |
| Series B Convertible Preferred Stock, $0.001 par value; 85 shares authorized; 0.85 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | - | - |
| Common stock, $0.001 par value; 675,000,000 shares authorized; 13,581,242 and 13,553,049 shares issued, 13,119,065 and 13,071,601 shares outstanding as of March 31, 2026 and December 31, 2025, respectively | 14 | 14 |
|---|---|---|
| Additional paid in capital | 102,096 | 102,059 |
| Treasury stock at cost; 462,117 and 481,448 shares at March 31, 2026 and December 31, 2025, respectively | (476) | (502) |
| Accumulated deficit | (91,257) | (90,578) |
| STOCKHOLDERS' EQUITY | 10,377 | 10,993 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $12,116 | $13,018 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.